로딩 중…
지수 로딩 중…
Mineralys Therapeutics, Inc.
MLYS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$24.63-1.99%
2026-06-18
Price Chart
Mineralys Therapeutics, Inc.+79.39%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.03B |
| Revenue | $0.00 |
| Net Income | $-152M |
| Total Assets | $653M |
| Net Assets | $638M |
| Value | |
| P/B | 3.18x |
| FCF Yield | -6.71% |
| Profitability | |
| ROE | -23.78% |
| ROA | -23.25% |
| Financial Health | |
| Debt Ratio | 2.31% |
| Total Debt | $0.00 |
| FCF | $-136M |
| Cash | $113M |
| Current Ratio | 44.33x |
| Performance | |
| 1Y Return | 79.39% |
| 1M Return | -5.38% |
| From 52W High | -48.31% |
| 1Y MDD | -52.46% |
| Trading | |
| Volume | 3,331,925 shares |
| Trading Value | $83M |
| Per Share | |
| EPS | $-1.92 |
| BPS | $8.03 |